A phase 1B study of the safety and tolerability of the mineralocorticoid fludrocortisone acetate in patients with geographic atrophy

被引：0
|
作者：
Hong, Thomas [1 ,2 ]
Chang, Andrew [2 ,3 ]
Maddess, Ted [4 ]
Provis, Jan [4 ,5 ]
Penfold, Philip [4 ,5 ]
机构：
[1] CUREOS, Sydney, NSW, Australia
[2] Sydney Retina, Sydney, NSW, Australia
[3] Univ Sydney, Save Sight Inst, Sydney, NSW, Australia
[4] Australian Natl Univ, Canberra, ACT, Australia
[5] EyeCo Pty Ltd, Melbourne, Vic, Australia
来源：
CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY | 2022年 / 50卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：955 / 955
页数：1
相关论文
共 50 条
  • [1] Phase 1B study of the safety and tolerability of the mineralocorticoid fludrocortisone acetate in patients with geographical atrophy
    Hong, Thomas
    Chang, Andrew
    Maddess, Ted
    Provis, Jan
    Penfold, Philip
    BMJ OPEN OPHTHALMOLOGY, 2022, 7 (01):
  • [2] Safety, tolerability and treatment effectiveness of chronic hepatitis B patients with pradefovir: a phase 1b multiple ascending dose study
    Jingrui, L.
    Junqi, N.
    Yanhua, D.
    Ning, X.
    Xiaoxue, Z.
    Xiaojiao, L.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S105 - S105
  • [3] A Phase 1b/2 Study of the Safety and Tolerability of Tinlarebant in Adolescent STGD1 Subjects
    Grigg, John R.
    Chen, Fred Kuanfu
    Chen, Ta-Ching
    Jamieson, Robyn V.
    Mata, Nathan L.
    Liao, Webber
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2022, 63 (07)
  • [4] A PHASE 1B/2A STUDY OF THE SAFETY, TOLERABILITY, PHARMACOKINETICS AND PHARMACODYNAMICS OF XMAB®5871 IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Jaraczewska-Baumann, M.
    Korkosz, M.
    Sulyok, G.
    Sramek, P.
    Rojkovich, B.
    Daniluk, S.
    Bartalos, J.
    Zack, D. J.
    Foster, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 481 - 481
  • [5] Safety and tolerability of veliparib combined with capecitabine plus radiotherapy in patients with locally advanced rectal cancer: a phase 1b study
    Czito, Brian G.
    Deming, Dustin A.
    Jameson, Gayle S.
    Mulcahy, Mary F.
    Vaghefi, Houman
    Dudley, Matthew W.
    Holen, Kyle D.
    DeLuca, Angela
    Mittapalli, Rajendar K.
    Munasinghe, Wijith
    He, Lei
    Zalcberg, John R.
    Ngan, Samuel Y.
    Komarnitsky, Philip
    Michael, Michael
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2017, 2 (06): : 418 - 426
  • [6] Phase 1b study to investigate the safety and tolerability of idelalisib in Japanese patients with relapsed/refractory follicular lymphoma and chronic lymphocytic leukemia
    Fukuhara, Noriko
    Kinoshita, Tomohiro
    Yamamoto, Kazuhito
    Nagai, Hirokazu
    Izutsu, Koji
    Yamamoto, Go
    Bhargava, Pankaj
    Rajakumaraswamy, Nishan
    Humeniuk, Rita
    Mathias, Anita
    Xing, Guan
    Fukui, Masato
    Tobinai, Kensei
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2020, 50 (12) : 1395 - 1402
  • [7] Results of a Phase 1b/2a Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of XmAb®5871 in Patients with Rheumatoid Arthritis (RA)
    Zack, Debra
    Baumann, Maria Jaraczewska
    Korkosz, Mariusz
    Suljok, Gabriella
    Sramek, Petr
    Rojkovich, Bernadette
    Daniluk, Stafan
    Bartalos, Janos
    Foster, Paul
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [8] Phase 1b study to assess the safety, tolerability, and clinical activity of pamiparib in combination with temozolomide in patients with locally advanced or metastatic solid tumors
    Stradella, Agostina
    Johnson, Melissa
    Goel, Sanjay
    Park, Haeseong
    Lakhani, Nehal
    Arkenau, Hendrik-Tobias
    Galsky, Matthew D.
    Calvo, Emiliano
    Baz, Vicente
    Moreno, Victor
    Saavedra, Omar
    Luen, Stephen J.
    Mu, Song
    Wan, Qiting
    Chang, Victoria
    Zhang, Wa
    Barve, Minal
    CANCER MEDICINE, 2024, 13 (13):
  • [9] A Phase 1b/2 Study of the Safety and Tolerability of Tinlarebant in Adolescent Patients Affected by Stargardt Disease-15 month preliminary data
    Grigg, John R.
    Chen, Fred Kuanfu
    Chen, Ta-Ching
    Jamieson, Robyn V.
    Scholl, Hendrik P.
    Mata, Nathan L.
    Quan Dong Nguyen
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [10] Immune checkpoint inhibition in sepsis: a Phase 1b randomized study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of nivolumab
    Hotchkiss, Richard S.
    Colston, Elizabeth
    Yende, Sachin
    Crouser, Elliott D.
    Martin, Greg S.
    Albertson, Timothy
    Bartz, Raquel R.
    Brakenridge, Scott C.
    Delano, Matthew J.
    Park, Pauline K.
    Donnino, Michael W.
    Tidswel, Mark
    Mayr, Florian B.
    Angus, Derek C.
    Coopersmith, Craig M.
    Moldawer, Lyle L.
    Catlett, Ian M.
    Girgis, Ihab G.
    Ye, June
    Grasela, Dennis M.
    INTENSIVE CARE MEDICINE, 2019, 45 (10) : 1360 - 1371
12345